The virus-killing 'bodyguards' that make lupus worse

May 4, 2018 by Kate Wighton, Imperial College London
Immune cells (green) malfunctioning and attacking kidney cells. Credit: Imperial College London

A type of cell that protects the body from viruses and cancer may make lupus worse, and trigger flare ups of the condition.

These are the findings of a study led by Imperial College London, published in the journal Science.

The researchers say the findings provide insight into why can worsen the condition or trigger a resurgence of symptoms – known as a "flare".

Lupus affects around one in 1000 people – approximately 30,000 in the UK.

The condition is an autoimmune disease which triggers the immune system to malfunction and start attacking the body. This can lead to joint and skin problems, and in severe cases can cause damage to the heart, lungs, brain and kidneys.

The initial causes are unknown, but genes are thought to play a role. The condition is nine times more common in women than in men, and usually strikes between the ages of 20 and 49.

In the new study, researchers investigated a particular component of the immune system called C1q. This molecule is part of a system called the complement system. This system helps raise the alarm when the body is attacked by an invader, such as a bacteria or virus, and helps coordinate a defence.

A small number of individuals are unable to make the molecule C1q, and as a result of this they develop Lupus.

When our protection malfunctions

Using a combination of mouse models and human cell samples, the team found C1q is important for regulating how the virus-killing immune cells consume their energy—a process called metabolism.

Specifically, C1q controls the survival and functions of a type of cell called cytotoxic T-cells, or CD8 T cells. These are like the bodyguards of the immune system, and destroy threats to the body such as viruses, or cells that have turned cancerous.

The team found that when number of these cytotoxic T-cells became too high, the immune system starts malfunctioning and attacking the body – and become worse. This may be why lupus patients may suffer a flare in symptoms when they contract a .

Viral trigger

Professor Marina Botto, lead author of the study from the Department of Medicine at Imperial, said:

"I've been working with lupus for many years, and we've only recently realised these cytotoxic cells – which have such a crucial role in protecting the against viruses, may also play a key role in the disease."

Professor Botto explained that although the initial trigger for lupus remains unknown, the condition could be sustained by viral infections that trigger an expansion of the cytotoxic T-cells.

Professor Botto adds that other studies have suggested that patients with higher levels of these cytotoxic T-cells tend to have more severe forms of autoimmune diseases.

The team are now conducting further studies with , to gain more insight into how these may be controlled.

Explore further: Study points to potential personalized approach to treating lupus

More information: "C1q restrains autoimmunity and viral infection by regulating CD8+ T cell metabolism" Science (2018). science.sciencemag.org/cgi/doi … 1126/science.aao4555

Related Stories

Study points to potential personalized approach to treating lupus

March 29, 2018
In individuals with lupus, immune cells attack the body's own tissue and organs as if they are enemy invaders. A new Yale-led study describes how a protein found in common bacteria triggers that auto-immune response. The ...

Deconstructing lupus—could some of its makeup be part of its cure?

February 20, 2018
Chandra Mohan, Hugh Roy and Lillie Cranz Cullen Endowed Professor of biomedical engineering, has received a $600,000 Target Identification in Lupus grant from the Lupus Research Alliance to address fundamental questions in ...

Team identifies potential cause for lupus

July 14, 2017
Leading rheumatologist and Feinstein Institute for Medical Research Professor Betty Diamond, MD, may have identified a protein as a cause for the adverse reaction of the immune system in patients suffering from lupus. A better ...

Protein's role in lupus development

December 5, 2017
Northwestern Medicine scientists have demonstrated that the loss of a protein called Bim in macrophages—a type of immune cell—leads to the development of lupus-like disease in mice. The findings, published in the Journal ...

Advancing our understanding of how the disease lupus is prevented in healthy individuals

October 31, 2016
A group of researchers at Tokyo Medical and Dental University(TMDU) have identified a molecule that stops the immune system from mistakenly reacting to a component of the body's own cells, which could improve our ability ...

Omega-3 fatty acid stops lupus trigger, but how?

June 1, 2017
Michigan State University scientists have received a $2.3 million, five-year National Institutes of Health grant to help uncover why an omega-3 fatty acid, known as DHA, is so effective in stopping a known trigger of lupus.

Recommended for you

A bad influence—the interplay between tumor cells and immune cells

October 16, 2018
Research at Huntsman Cancer Institute (HCI) at the University of Utah (U of U) yielded new insights into the environment surrounding different types of lung tumors, and described how these complex cell ecosystems may in turn ...

Function of neutrophils during tumor progression unraveled

October 15, 2018
Researchers at The Wistar Institute have characterized the function of neutrophils, a type of white blood cells, during early stages of tumor progression, showing that they migrate from the bone marrow to distant sites and ...

Immune health maintained by meticulously ordered DNA

October 15, 2018
Walter and Eliza Hall Institute researchers have revealed how immune health is maintained by the exquisite organisation skills of a protein called Pax5.

New immunotherapy targeting blood-clotting protein

October 15, 2018
Normally, the blood protein fibrin does not enter the brain. But in several neurological disorders, the blood-brain barrier—which keeps large molecules in the blood from entering the brain—becomes abnormally permeable, ...

Enzyme that triggers autoimmune responses from T-cells in patients with MS found

October 11, 2018
A team of researchers from Switzerland, the U.S. and Spain has isolated an enzyme that triggers an autoimmune response from T-cells in patients with MS. In their paper published in the journal Science Translational Medicine, ...

Scientists reveal new cystic fibrosis treatments work best in inflamed airways

October 11, 2018
A new UNC School of Medicine study shows that two cystic fibrosis (CF) drugs aimed at correcting the defected CFTR protein seem to be more effective when a patient's airway is inflamed. This is the first study to evaluate ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.